Related Experiment Videos
Quantifying the density of Friedman's pathogenic emotions (AIAI)
M W Ketterer1, W R Lovallo, M A Lumley
1Department of Psychiatry, Henry Ford Health Sciences Center, Case Western Reserve University School of Medicine, Detroit.
Summary
Chronic negative emotions, like aggravation, irritation, anger, and impatience (AIAI), link psychosocial factors to ischemic heart disease (IHD). The Framingham Type A Scale best identified AIAI, even when patients denied it.
Area of Science:
- Psychology
- Cardiology
- Psychosomatic Medicine
Background:
- Psychosocial factors influence ischemic heart disease (IHD) through psychoneuroendocrine and psychobehavioral pathways.
- Chronic negative emotional arousal is a key mediator, but denial can be a measurement error.
- Understanding the association between negative emotions and IHD is crucial for prevention and treatment.
Purpose of the Study:
- To examine the association between patient- and proxy-reported chronic aggravation, irritation, anger, and impatience (AIAI) and established measures of Type A Behavior or hostility.
- To assess the reliability of different Type A/hostility measures in relation to self- and proxy-reported AIAI.
- To investigate the role of denial in the reporting of AIAI.
Main Methods:
- Two samples were used: 175 men undergoing coronary angiography and 56 age/SES-matched healthy males.
- Patient-reported and spouse/friend-reported AIAI were collected.
- Four measures of Type A Behavior/hostility were assessed: Framingham Type A Scale (FTAS), Cook-Medley Hostility Scale, Type A Structured Interview, and a Hostility rating from the Structured Interview.
Main Results:
- Chronic AIAI was underreported by patients compared to spouse/friend reports; Depression and Anxiety/Worry were overreported by patients.
- All four Type A/hostility measures correlated significantly with both patient- and proxy-reported AIAI.
- The Framingham Type A Scale (FTAS) demonstrated the highest reliability across both reporting sources and was negatively associated with denial of AIAI.
Conclusions:
- The Framingham Type A Scale is a reliable measure for assessing chronic AIAI, even in the presence of patient denial.
- Addressing chronic negative emotions, particularly those related to Type A behavior, may be important in managing the risk of ischemic heart disease.
- Future research should consider both patient and proxy reports to mitigate measurement errors like denial in psychosomatic studies.